- Home
- NCL vs PRPH Comparison
NCL vs PRPH Comparison
Compare NCL & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- PRPH
- Stock Information
- Founded
- NCL 2013
- PRPH 1989
- Country
- NCL United States
- PRPH United States
- Employees
- NCL N/A
- PRPH N/A
- Industry
- NCL
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- NCL
- PRPH Health Care
- Exchange
- NCL Nasdaq
- PRPH Nasdaq
- Market Cap
- NCL 11.6M
- PRPH 10.7M
- IPO Year
- NCL 2023
- PRPH 1997
- Fundamental
- Price
- NCL $0.42
- PRPH $0.35
- Analyst Decision
- NCL
- PRPH
- Analyst Count
- NCL 0
- PRPH 0
- Target Price
- NCL N/A
- PRPH N/A
- AVG Volume (30 Days)
- NCL 929.3K
- PRPH 2.4M
- Earning Date
- NCL 05-19-2025
- PRPH 05-08-2025
- Dividend Yield
- NCL N/A
- PRPH N/A
- EPS Growth
- NCL N/A
- PRPH N/A
- EPS
- NCL N/A
- PRPH N/A
- Revenue
- NCL $15,576,857.00
- PRPH $6,770,000.00
- Revenue This Year
- NCL N/A
- PRPH $221.82
- Revenue Next Year
- NCL N/A
- PRPH N/A
- P/E Ratio
- NCL N/A
- PRPH N/A
- Revenue Growth
- NCL 47.13
- PRPH N/A
- 52 Week Low
- NCL $0.15
- PRPH $0.22
- 52 Week High
- NCL $0.69
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- NCL 88.47
- PRPH 53.48
- Support Level
- NCL $0.27
- PRPH $0.26
- Resistance Level
- NCL $0.46
- PRPH $0.38
- Average True Range (ATR)
- NCL 0.04
- PRPH 0.06
- MACD
- NCL 0.02
- PRPH 0.01
- Stochastic Oscillator
- NCL 85.71
- PRPH 57.27
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.